FindTrial
Sign In

The incidence and associated risk factor of secondary primary malignancy in patients with thyroid cancer: National Health Insurance Cohort Study

The incidence and associated risk factor of secondary primary malignancy in patients with thyroid cancer: National Health Insurance Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0009197
Enrollment
2500000
Registered
2024-02-23
Start date
2021-02-01
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Korea University Anam Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with ICD 10 code of thyroid cancer

Exclusion criteria

Exclusion criteria: ? Patients who received with thyroid hormone or radioiodine therapy due to other thyroid disease ? Patients had thyroid surgery for other thyroid disease prior to diagnosis of thyroid cancer ? Patients who treated for cancers other than thyroid prior to diagnosis of thyroid cancer

Design outcomes

Primary

MeasureTime frame
The incidence of secondary primary malignancy;The all cause mortality or thyroid cancer specific mortality—

Secondary

MeasureTime frame
The associated risk factor of secondary primary malignancy—

Countries

Korea, Republic of

Contacts

Public ContactJimi Choi

Korea University Anam Hospital

jjimchoi@gmail.com+82-2-9073-6493

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026